Literature DB >> 17460415

Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle.

Jean-Yves Blay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460415     DOI: 10.1159/000101702

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


× No keyword cloud information.
  5 in total

1.  A genome-wide expression profile of noncoding RNAs in human osteosarcoma cells as they acquire resistance to cisplatin.

Authors:  Harshita Sharma; Divya Niveditha; Rajdeep Chowdhury; Sudeshna Mukherjee; Shibasish Chowdhury
Journal:  Discov Oncol       Date:  2021-10-20

2.  Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model.

Authors:  Ram Mohan Ram Kumar; Matthias Je Arlt; Aleksandar Kuzmanov; Walter Born; Bruno Fuchs
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

3.  The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.

Authors:  Sudeshna Mukherjee; Subhra Dash; K Lohitesh; Rajdeep Chowdhury
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

4.  Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.

Authors:  Jantine Posthumadeboer; Pim W van Egmond; Marco N Helder; Renée X de Menezes; Anne-Marie Cleton-Jansen; Jeroen A M Beliën; Henk M W Verheul; Barend J van Royen; Gert-Jan J L Kaspers; Victor W van Beusechem
Journal:  Oncotarget       Date:  2012-10

5.  Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma.

Authors:  Kheshwant S Gill; Philana Fernandes; Brian Bird; Declan M Soden; Patrick F Forde
Journal:  Oncotarget       Date:  2018-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.